Application bulletins
These case studies were presented by SKYEPHARMA during CSF Cambridge 2018 to highlight the development of multilayer and tab-in-tab dosage forms on STYL’One Evo while saving time and cost during the development phase. Controlled release forms are more complex to design but very interesting to deliver a sustained API dose or a delayed pulse of API to the patient.

Comments
No comments posted yet.
Add a comment